ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,242Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 2056

$501K Total Retail Price of All Prescriptions

Rank: 76 out of 2056

458 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

23% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 5,344 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 556 321 1 1
HYDROCODONE-ACETAMINOPHEN 412 267 S3 2 5
SIMVASTATIN 335 223 3 2
OMEPRAZOLE 254 114 4 4
GABAPENTIN 238 142 5 14
LEVOTHYROXINE SODIUM 232 164 6 3
METFORMIN HCL 200 95 7 8
LOSARTAN POTASSIUM 192 150 8 13
MORPHINE SULFATE ER 191 65 S2 9 36
AMLODIPINE BESYLATE 184 133 10 6
RANITIDINE HCL 175 84 11 22
PROAIR HFA 174 80 12 29
ATENOLOL 158 109 13 10
HYDROCHLOROTHIAZIDE 155 101 14 7
CITALOPRAM HBR 129 74 15 15
METOPROLOL TARTRATE 128 116 16 11
TRAZODONE HCL 123 45 17 21
LOVASTATIN 120 84 18 16
FUROSEMIDE 120 84 18 9
SPIRIVA 115 63 20 42
WARFARIN SODIUM 104 69 21 12
ALLOPURINOL 101 76 22 32
ZOLPIDEM TARTRATE 100 61 23 23
OXYCODONE-ACETAMINOPHEN 99 23 S2 24 40
CARVEDILOL 99 53 24 35
LANTUS SOLOSTAR 99 73 24 80
FLUOXETINE HCL 95 58 27 33
TRAMADOL HCL 94 40 28 27
PREDNISONE 94 63 28 38
LANTUS 90 53 30 41
NORTRIPTYLINE HCL 90 27 30 100
POTASSIUM CHLORIDE 86 62 32 18
ADVAIR DISKUS 84 78 33 51
OXYCODONE HCL 80 33 S2 34 24
SERTRALINE HCL 77 38 35 25
COMBIVENT 74 50 36 138
HYDROXYZINE HCL 71 32 R 37 223
NAPROXEN 63 20 38 84
CLOPIDOGREL 61 45 39 72
VENLAFAXINE HCL ER 60 25 40 82
BACLOFEN 57 24 41 86
FLUTICASONE PROPIONATE 57 34 41 31
METOPROLOL SUCCINATE 56 32 43 19
KETOCONAZOLE 56 0 43 199
OXYBUTYNIN CHLORIDE 52 37 45 79
SPIRONOLACTONE 52 17 45 63
METHOCARBAMOL 51 0 R 47 65
BUPROPION HCL SR 51 0 47 104
CYCLOBENZAPRINE HCL 50 11 R 49 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.